Member Info for BOJO2020

Yeah,

200 million warrants needed washing so can’t be many if any left looking at previous volumes

Hmm,

Target achieved but did not expect outstanding news so I will hold a little longer…

https://www.australianmining.com.au/news/alien-discovers-out-of-this-world-silver-grades/

Thanks Chester, Bermuda

That covers it. I usually use Microsoft word to proof read back my own work. I will do the same with RNS’s from now on! The devil is in the detail as always. Still I am very patient so no big deal.

ATB

Am I missing something? Blinded by hope maybe!

The report was up to Nov 21. Hence 16 covidity subjects dosed as confirmed by our CEO on 3rd of December 21. So how do we arrive at still only 16 subjects dosed in the Covidity trial to date? An assumption? Ok I realise that there has been no indication that more than 16 subjects have been dosed. It would therefore also be an assumption to say more have since been dosed, but the report is not up to Jan 22 is it.

I have read the RNS several times. Like I say, maybe with rose tinted glasses? I followed the link on the website but still no clearer to me.

I expect this back at 20/21p over coming days. Managed to add 10892 yesterday. What a gift…As others say, nothing has changed. I am happy with the progress made by November last year.

https://www.lse.co.uk/rns/UFO/alien-intersects-bonanza-silver-at-elizabeth-hill-vqo84zdkxwoehn7.html

Think they have only gone and blown the bloody doors off!

Getting worse lol!

Managed to grab a few around 30p. Hoping for 30%…

is being created by tension between Russia and Ukraine IMO.

Xviolet,

I think the contrary is likely to be true. Omicron may well mitigate the bodies ability to mount an immune response via interferon action. However SNG are intruding nebulised interferon. It is there for quite possible that it could prove as effective or even more so. We should note that Omicron effects the upper and not lower airway as all other VOC have done. That in itself would make any study involving SNG and omicron interesting.

That’s the thing with SNG. As novel therapeutic they have to prove EVERYTHING! All data collected is in itself novel.

Maybe JVT saw the direction of travel and did not like it..:

The other scientists that remain in an official capacity have a voice on the inside and don’t have to shout to be heard from the outside.

I think all politicians are all the same no matter what colours the pin to the mast. I just don’t like them.

It’s a necessary evil for scientists to be involved with politicians but it was never going to be a good mix. Fact vs spin and all the other bull.

Re lifting the restrictions - yes I think it’s too early, or at least people seem to be interpreting it as Omicron is nothing to worry about (What ever happened to covid…)

Talking of the next big thing…

1. Sclp
2. Angle Plc
3. IQAI
4. REDX

All homing in on cancer. All part of my cancer/disease portfolio. These are already making a difference or are about too.

https://www.lse.co.uk/rns/AGL/potential-in-immunotherapy-treatment-selection-970az4one5uwttr.html

Outstanding research with much anticipated
Ovarian Cancer Study to come.

Xviolet,

Richard Marsden looks as solid and trustworthy as they come doesn't he...He is however unlikely to express limitations of the therapeutic but on the other hand he is not going to over egg its virtues. The science has spoken for itself thus far but regulators will ensure it must perform at the highest levels imaginable to achieve greatness.

My opinion for what its worth is that a small holding may be worth a great sum in years to come but I would not be brave enough to risk sizeable amounts due to the nature of the hurdles it must overcome. As always you judgement appears good.

Good Luck!

That’s a good question MJ.

I would say that many immunologists have been on the news channel’s testifying that variants are expected to become milder. However the delta variant proved that theory wrong. I guess it should be said variants are ‘likely’ to be less harmful but what ever language they use people will interpret it how they wish.

Let’s not forget that SNG have a lot of data behind them. It is proven to work and this will put them in a much stronger position than they had been before the pandemic. So in that respect it isn’t that this therapeutic will save the world as plastered on that bulletin board, more so that it has clinical benefit and will save lives.

I think the big question is can this get to market. That’s not a question anybody can answer so we will have to wait and see. As with any pharma investment, one has the option to be in or out at different stages and therefore timing is essential. FOMO on this one is the enemy IMO.

The potential for Parsortix is huge.

Whilst in the first instance it will not be used for diagnostic benefit, one can imagine scenarios in which it can give compelling evidence in hard to treat scenarios such as pancreatic cancers where surgeons are unable to take even a biopsy let alone remove tumours. In such cases the need for monitoring of treatments is essential.

So a possible diagnostic and most certainly a monitoring tool. I actually do understand why FDA are not just waving this through. However one has to ask, why take so long? Can approval not be given with strong conditions until both FDA, clinicians and scientists learn how to use Parsortix properly.

If you look at Polarean, it was only possible for them to apply a few years back. Maybe FDA need to be flexible without fear. Indeed they could be flexible and make an exception for a tool like Parsortix that has such wide reaching potential.

Thing is of course, regulatory body’s will be regulatory body’s…

I added last week @ £1.10 MJ. My strategy is very conservative now. I am willing to miss out on the FDA rise as I bought most of my original holding @ 34.5p. I think braver Investors will make more money than me but I am happy to make something.

For the record, I believe that if Angle get FDA, it will beat Novacyt rise etc. so I don’t mind missing out on 50p to £1.

Whoever the PM is, they could do with cashing in on the kudos of Covidity. Excellent point krafty. It reminds me of Trump standing at the lectern wallowing (like a great ‘tangoed walrus?’) as the first gen vaccines were rolled out.

I agree. Only positive ovarian study news or FDA approval would have been more important than this. Yet again the markets are not quite picking up on this amazing opportunity. Brilliant. Well done Angle and thanks for the heads up Bermuda.